ArticleAntiviral chemistry & chemotherapy

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa.

Kerri J Penrose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.